Outcomes over the first two years of treatment with mepolizumab in severe asthma. Elsey L, Pantin T, Holmes LJ, Tavernier G, et al. Eur Respir J 2021 Oct 28. pii: 13993003.01313-2021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elsey L, Pantin T, Holmes LJ, Tavernier G, et al. Outcomes over the first two years of treatment with mepolizumab in severe asthma. Eur Respir J 2021 Oct 28. pii: 13993003.01313-2021.
PMID: 34711539